11/14
06:34 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Medium
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
11/14
05:10 pm
uncy
Form 8-K Unicycive Therapeutics, For: Nov 14
Medium
Report
Form 8-K Unicycive Therapeutics, For: Nov 14
11/14
05:09 pm
uncy
Form 424B5 Unicycive Therapeutics,
Medium
Report
Form 424B5 Unicycive Therapeutics,
11/14
04:53 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Octagon Capital Advisors LP
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Octagon Capital Advisors LP
11/14
04:46 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Nantahala Capital Management, LLC
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Nantahala Capital Management, LLC
11/14
04:26 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
11/14
03:02 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: GREAT POINT PARTNERS LLC
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: GREAT POINT PARTNERS LLC
11/12
09:12 am
uncy
Form 8-K Unicycive Therapeutics, For: Nov 12
Medium
Report
Form 8-K Unicycive Therapeutics, For: Nov 12
11/12
06:40 am
uncy
Form 10-Q Unicycive Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Unicycive Therapeutics, For: Sep 30
10/28
07:30 am
uncy
Form 8-K Unicycive Therapeutics, For: Oct 28
Medium
Report
Form 8-K Unicycive Therapeutics, For: Oct 28